降糖药物的研究进展(3)
[12]Bavirti S，Tayek JA.Low-dose glyburide reduces glucose production rates in patients with impaired fasting glucose[J].Metabolism，2003，52(4):407-412.
[13]Drzewoski J，Czupryniak L.Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus:a retrospective study[J].Med Sci Monit，2003，9(6):240-243.
[14]Pavo I，Jermendy G,Varkonyi TT,et al.Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes[J].J Clin Endocrinol Metab，2003，88(4):1637-1645.
[15]H llsten K，Virtanen KA，L nnqvist F，et al.Rosiglitazone but not metformin enhances insulin and exercise stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes[J].Diabetes，2002，51(12):3479-3485.
[16]Chiaeeon JL，Josse RG，Gomis R，et al.Acarbose treatment and the risk of cardiovascular disease and hypertension in impaired glucose tolerance:the STOP-NIDDM trial[J].JAMA，2003，290(4):486-494.
[17]Delgado H，Lehmann T，Bobbioni-Harsch E，et al.Acarbose improves indirectly both insulin resistance and secretion in obese type 2 diabetic patients[J].Diabetes Metab，2002，28(3):195-200.
[18]Scheen AJ.Is there a role for α-glucosigase inhibitors in the prevention of type 2 diabetes mellitus[J].Drugs，2003，53(10):933-951.
[19]Ole Schmitz.治疗2型糖尿的新药和方法[J].国外医学内分泌学分册, 2005，(3):79.
(收稿日期：2007-10-08), http://www.100md.com(晏 黎 田 静)
[13]Drzewoski J，Czupryniak L.Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus:a retrospective study[J].Med Sci Monit，2003，9(6):240-243.
[14]Pavo I，Jermendy G,Varkonyi TT,et al.Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes[J].J Clin Endocrinol Metab，2003，88(4):1637-1645.
[15]H llsten K，Virtanen KA，L nnqvist F，et al.Rosiglitazone but not metformin enhances insulin and exercise stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes[J].Diabetes，2002，51(12):3479-3485.
[16]Chiaeeon JL，Josse RG，Gomis R，et al.Acarbose treatment and the risk of cardiovascular disease and hypertension in impaired glucose tolerance:the STOP-NIDDM trial[J].JAMA，2003，290(4):486-494.
[17]Delgado H，Lehmann T，Bobbioni-Harsch E，et al.Acarbose improves indirectly both insulin resistance and secretion in obese type 2 diabetic patients[J].Diabetes Metab，2002，28(3):195-200.
[18]Scheen AJ.Is there a role for α-glucosigase inhibitors in the prevention of type 2 diabetes mellitus[J].Drugs，2003，53(10):933-951.
[19]Ole Schmitz.治疗2型糖尿的新药和方法[J].国外医学内分泌学分册, 2005，(3):79.
(收稿日期：2007-10-08), http://www.100md.com(晏 黎 田 静)